Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.4%

22 terminated/withdrawn out of 134 trials

Success Rate

82.0%

-4.5% vs industry average

Late-Stage Pipeline

12%

16 trials in Phase 3/4

Results Transparency

67%

67 of 100 completed trials have results

Key Signals

5 recruiting67 with results20 terminated

Enrollment Performance

Analytics

N/A

78(73.6%)

Phase 3

10(9.4%)

Phase 1

7(6.6%)

Phase 4

6(5.7%)

Phase 2

5(4.7%)

106Total

N/A(78)

Phase 3(10)

Phase 1(7)

Phase 4(6)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (134)

Showing 20 of 134 trials

NCT00761618Phase 2Active Not Recruiting

Intrapleural Catheter Daily Versus Three Times a Week Drainage

Role: collaborator

NCT04634916Not ApplicableRecruiting

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

Role: lead

NCT05504070Not ApplicableActive Not Recruiting

Venclose digiRF System Post Market Study

Role: lead

NCT03506308Not ApplicableActive Not Recruiting

Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae

Role: lead

NCT05945329Not ApplicableRecruiting

Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation

Role: lead

NCT03911700Not ApplicableRecruiting

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

Role: lead

NCT06934486Not Yet Recruiting

Observational Study of TissuePatch SF in Prevention of Air Leaks Following Lung Resection

Role: lead

NCT05556681Not ApplicableCompleted

Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries

Role: lead

NCT06669806Not ApplicableRecruiting

Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension

Role: lead

NCT07016698Not ApplicableRecruiting

Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)

Role: lead

NCT04261686Not ApplicableCompleted

Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

Role: lead

NCT07282860Not ApplicableEnrolling By Invitation

An Evaluation of the PureWick™ Male External Catheter Versus an Established Comparator Overnight in the Home Setting for Incontinence in Adult Males

Role: lead

NCT02649894Not ApplicableCompleted

Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter

Role: lead

NCT02682420Not ApplicableTerminated

everlinQ endoAVF Post Market Study

Role: lead

NCT03708770Not ApplicableCompleted

everlinQ Endovascular Access System Enhancements (EASE) Study

Role: lead

NCT00799812Phase 3Completed

Test for Pre Operative Skin Preparations

Role: lead

NCT03708562Not ApplicableCompleted

everlinQ Endovascular Access Systems Enhancements (EASE-2) Study

Role: lead

NCT03140254Phase 2Completed

Evaluating Safety and Effectiveness of Octenidine Dihydrochloride

Role: lead

NCT01366417Phase 4Completed

Topical Antimicrobial Effectiveness Testing

Role: lead

NCT01314703Phase 4Completed

Topical Antimicrobial Effectiveness Testing

Role: lead